Add Company
Join Now

XyloCor Therapeutics Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • XyloCor Therapeutics's estimated annual revenue is currently $1.1M per year.(i)
  • XyloCor Therapeutics's estimated revenue per employee is $61,200

Employee Data

  • XyloCor Therapeutics has 18 Employees.(i)
  • XyloCor Therapeutics grew their employee count by 38% last year.

XyloCor Therapeutics's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
SVP Technology, Manufacturing & QualityReveal Email/Phone
3
VP Clinical OperationsReveal Email/Phone
4
Chief Technology Officer and Head Technical OperationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M5714%N/AN/A
#2
$205.9M14424%N/AN/A
#3
$52.4M4116%N/AN/A
#4
$21.7M1935%N/AN/A
#5
$5.5M603%N/AN/A
#6
$5.1M5610%N/AN/A
#7
$1.1M18-44%N/AN/A
#8
$0.3M50%N/AN/A
#9
$0.1M20%N/AN/A
#10
$2.7M336%N/AN/A
Add Company

What Is XyloCor Therapeutics?

XyloCor Therapeutics is a development-stage, biotechnology company dedicated to developing first-in-class gene therapies for patients with unmet medical need in cardiovascular disease.

keywords:N/A

N/A

Total Funding

18

Number of Employees

$1.1M

Revenue (est)

38%

Employee Growth %

N/A

Valuation

N/A

Accelerator

XyloCor Therapeutics News

2022-04-06 - Gene Therapies & Associated Vectors 2022: Intellectual ...

DUBLIN, April 13, 2022 /PRNewswire/ -- The "Gene Therapies ... Wellstat Biologics; Xenetic Biosciences; XyloCor Therapeutics; Zycos.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.9M18-10%N/A
#2
$3.5M20-31%N/A
#3
$1.8M21-9%N/A
#4
$2.1M21-5%N/A
#5
$2.1M21-12%N/A